Literature DB >> 28972060

Is Load-Induced Ventricular Hypertrophy Ever Compensatory?

Gabriele G Schiattarella1, Theodore M Hill1, Joseph A Hill2.   

Abstract

Entities:  

Keywords:  animal models; cardiac myocytes; clinical trial; growth; hypertrophy; left ventricle

Mesh：

Year:  2017        PMID： 28972060      PMCID： PMC5690548          DOI： 10.1161/CIRCULATIONAHA.117.030730

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  A Few Applications of a Physical Theorem to Membranes in the Human Body in a State of Tension.

Authors:  R H Woods
Journal:  J Anat Physiol       Date:  1892-04

2.  Compensatory hyperfunction of the heart and cardiac insufficiency.

Authors:  F Z MEERSON
Journal:  Circ Res       Date:  1962-03       Impact factor: 17.367

Review 3.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

4.  Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.

Authors:  J A Hill; M Karimi; W Kutschke; R L Davisson; K Zimmerman; Z Wang; R E Kerber; R M Weiss
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

5.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808
  5 in total
  9 in total

Review 1.  New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Giacomo Frati; Junichi Sadoshima
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

Review 2.  Emerging therapeutic targets for cardiac hypertrophy.

Authors:  Alexander J Winkle; Drew M Nassal; Rebecca Shaheen; Evelyn Thomas; Shivangi Mohta; Daniel Gratz; Seth H Weinberg; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2022-01-27       Impact factor: 6.902

3.  Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.

Authors:  Jinliang Li; Yuliang Tan; Catherine L Passariello; Eliana C Martinez; Michael D Kritzer; Xueyi Li; Xiaofeng Li; Yang Li; Qian Yu; Kenneth Ohgi; Hrishikesh Thakur; John W MacArthur; Jan R Ivey; Y Joseph Woo; Craig A Emter; Kimberly Dodge-Kafka; Michael G Rosenfeld; Michael S Kapiloff
Journal:  Circulation       Date:  2020-09-16       Impact factor: 29.690

4.  Human antigen R as a therapeutic target in pathological cardiac hypertrophy.

Authors:  Lisa C Green; Sarah R Anthony; Samuel Slone; Lindsey Lanzillotta; Michelle L Nieman; Xiaoqing Wu; Nathan Robbins; Shannon M Jones; Sudeshna Roy; A Phillip Owens; Jeffrey Aube; Liang Xu; John N Lorenz; Burns C Blaxall; Jack Rubinstein; Joshua B Benoit; Michael Tranter
Journal:  JCI Insight       Date:  2019-02-21

5.  The black sheep of class IIa: HDAC7 SIKens the heart.

Authors:  Joshua G Travers; Tianjing Hu; Timothy A McKinsey
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

6.  FoxO1-Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth.

Authors:  Anwarul Ferdous; Zhao V Wang; Yuxuan Luo; Dan L Li; Xiang Luo; Gabriele G Schiattarella; Francisco Altamirano; Herman I May; Pavan K Battiprolu; Annie Nguyen; Beverly A Rothermel; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Nat Commun       Date:  2020-05-21       Impact factor: 14.919

7.  Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.

Authors:  Yuxuan Luo; Nan Jiang; Herman I May; Xiang Luo; Anwarul Ferdous; Gabriele G Schiattarella; Guihao Chen; Qinfeng Li; Chao Li; Beverly A Rothermel; Dingsheng Jiang; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2021-04-06       Impact factor: 29.690

8.  Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.

Authors:  Ekaterina Ovchinnikova; Martijn Hoes; Kirill Ustyantsev; Nils Bomer; Tristan V de Jong; Henny van der Mei; Eugene Berezikov; Peter van der Meer
Journal:  Stem Cell Reports       Date:  2018-02-15       Impact factor: 7.765

9.  Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure.

Authors:  Gabriele G Schiattarella; Nicola Boccella; Roberta Paolillo; Fabio Cattaneo; Valentina Trimarco; Anna Franzone; Stefania D'Apice; Giuseppe Giugliano; Laura Rinaldi; Domenica Borzacchiello; Alessandra Gentile; Assunta Lombardi; Antonio Feliciello; Giovanni Esposito; Cinzia Perrino
Journal:  Front Physiol       Date:  2018-05-28       Impact factor: 4.566
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.